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Background: Several studies in the past have reported inconclusive evidences on association of smoking and
migraine. Nevertheless, no study so far reported association of smokeless tobacco with migraine. The objective of
this study was to examine the association of smoked and smokeless tobacco use with migraine.
Methods: A hospital-based case–control study was conducted at the neurology outpatient department of a tertiary
care hospital in Dhaka, Bangladesh. We enrolled 138 migraine cases diagnosed during March-September 2010 in
neurology outpatient department, and 276 gender and age matched healthy controls from among their attendants.
Diagnosis of migraine was based on the International Headache Society criteria. Use of smokeless tobacco and
smoking (cigarette/bidi/hukka) were determined by an interviewer administered questionnaire.
Results: Among the cases, 52.9% were overall tobacco users; 24.6% were only smokers, 15.9% only smokeless tobacco
users and 12.3% used both. The respective figures among controls were 14.5%, 7.2%, 6.9% and 0.4% (P <0.001 for all).
The conditional logistic regression analysis found that migraine had higher odds of exposure to smoked tobacco use,
smokeless tobacco use, and both compared to control after adjusting for confounding variables (alcohol drinking,
insufficient sleep, mental stress, and number of family members); adjusted odds ratio (aOR) was 6.6 (95% confidence
interval [CI] = 2.2-19.6, P = 0.001), 5.8 (95%CI = 1.9-17.4, P = 0.001), and 54.2 (95%CI = 4.3-684.4, P = 0.002), respectively.
The aOR of cigarette/bidi/hukka smoking for different doses was 5.5 (95%CI = 1.2-24.8, P = 0.027) for 1–5 times per day,
6.3 (95%CI = 1.8-21.2, P = 0.003) for 6–10 times per day, and 6.7 (95%CI = 1.9-23.2, P = 0.003) for >10 times per day
relative to non users.
Conclusions: Both smoked and smokeless tobaccos were found to be associated with migraine. There is a need to
incorporate smokeless tobacco along with smoked tobacco into the anti-tobacco awareness programs to reduce the
burden of migraine in Bangladesh.
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Migraine (without aura) was defined as recurring headache
disorder that manifest in the form of attack, last 4–72 hours,
unilateral, have a pulsating quality, moderate to severe in
intensity, aggravated by routine physical activity and are
associated with nausea or vomiting, photophobia and
phonophobia [1]. It is a chronic neurovascular condition* Correspondence: basarcmc@yahoo.com
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reproduction in any medium, provided the orwhich occurs up to 15% of adult population in the Western
world [2]. The burden of this disease is huge, as during the
episodic attack, 90% of them experienced moderate to
severe pain, 75% had some sort of disability, and 35% were
confined to bed [3,4]. It is regarded as the 20th leading cause
of years lived with disability (YLDs) at global level and is
the 9th leading cause of disability in women [1]. It is one of
the most common forms among the headache disorders
affecting the private, social and work life of those afflicted.
Repeated headache attacks and constant fear of the next,
damage family life, social life and employment. It is mostlytd. This is an Open Access article distributed under the terms of the Creative
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well. There is a dearth in population-based studies with
regard to the burden of migraine in Bangladesh. One
study reported that migraine is responsible for 26% of
all headaches in Bangladesh [5].
Stress, smoking, pattern of sleep, weather change, missing
a meal, bright light, certain food and alcohol consumption
have been reported as major triggers of migraine [6-8].
Several studies demonstrated the relationship between
smoking and migraine with inconsistent results [2,7-15].
However, it has not been examined if smokeless tobacco,
which is highly prevalent in South Asian countries [16], is
associated with migraine or not. In this region, smoked
tobacco includes cigarettes, bidi (hand-rolled cigarette),
hukka (water pipe for consuming smoked tobacco), while
smokeless tobacco includes dried tobacco (dried tobacco
leaf with betel leaf), zarda (mixture of dried tobacco leaf,
spices and vegetable dyes), and gul (tobacco powder). The
use of smoked tobacco in Bangladesh is much higher in
males (44.7%) than females (1.5%); however, smokeless
tobacco use is almost similar in both males (26.4%) and
females (27.9%) [17,18].
The purpose of this study was to examine the relation-
ship of both smoking and smokeless tobacco with migraine




Cases were 138 clinically confirmed migraine patients
attended the neurology outpatient department (OPD)
of Bangabandhu Sheikh Mujib Medical University
(BSMMU) - a tertiary care hospital in Dhaka. Bangladesh
for follow-up visits between March and September 2010.
Inclusion criteria were: (1) migraine without aura diag-
nosed according to the criteria of the International
Headache Society (IHS) [19], and (2) not suffering
from known case of psychiatric illness, hypertension,
hypothyroidism, or irregular menstruation. Pregnant
women were not included in the study.
Controls
Controls were 276 attendants of the cases. Two controls
were matched to each case by gender and age (± 5 years).
Inclusion criteria were: (1) family relative of the patient, (2)
person without any history of migraine, (3) not suffering
from psychiatric illness, hypertension, hypothyroidism,
irregular menstruation, and (4) not pregnant.
Data collection
Patients/attendants aged 12 years or above were in-
cluded in the study. Data were collected using an
interviewer-administered semi-structured questionnaire
which was developed after intensive literature reviewand consultation with experts. The questionnaire had
three parts; socio-demographic characteristics, tobacco
use, and other possible risk factors (insufficient sleep,
alcohol use, and mental stress). It was piloted among 15
migraine patients and 15 controls and necessary amend-
ments were made according to the responses and sug-
gestions of the interviewers. The respondents those who
consumed any form of tobacco (smoked or smokeless)
almost regularly during at least for the last six months
were considered as tobacco user. The respondents were
asked whether they consumed any alcoholic drink in the
last two weeks. Insufficient sleep was considered as
sleeping less than eight hours per day [11]. Mental stress
was assessed based on the subjective judgment of the
respondents. Before data collection, informed written
consent was taken from the respondents. Objectives,
procedure, risks, and benefits of participation in the
study were included in the informed consent sheet. The
participants were ensured that participation was voluntary
and they were free to withdraw themselves at any time
without any unwanted consequences. Moreover, confiden-
tiality of collected data was maintained using a code for
each respondent. Privacy of the participants was also
maintained during data collection by interviewing into a
separate room. A female health care provider was present
during the interview of female respondents. The study
was reviewed and approved by the Ethical Review
Committee of National Institute of Preventive and Social
Medicine (NIPSOM), Dhaka.
Statistical analyses
Statistical analyses were performed with the Statistical
Package for the Social Science, version 18.0 (SPSS, Chicago,
IL, USA). Student's t test for continuous variables and the
chi square test for categorical variables were used in the
assessment of differences between the two groups when
appropriate. All the statistical tests were two-tailed
and P values <0.05 were considered as statistically sig-
nificant. Exposure variables and confounders were screened
for inclusion in an initial multivariable conditional logistic
regression model. Candidate variables with P values <0.05
were included in the multivariable logistic regression
model. Separate logistic regression models were built
based on the type of tobacco use (nonusers, smokeless
tobacco users, smokers) and frequency of tobacco use
(without smokeless tobacco users).
Results
Comparative features of cases and controls are listed in
Table 1. The ages of cases and controls were identical.
Cases and controls were similar with regard to educa-
tion, marital status, income, and occupational status, but
the former group had larger family size. More cases were
smokeless tobacco users and smokers compared to
Table 1 Comparative features of cases and controls
Cases Controls P value
Age, mean (±SD), yrs 27.7 (8.9) 27.7 (8.9) 0.994
Gender 1.000
Male 46 (33.3) 92 (33.3)
Female 92 (66.7) 184 (66.7)
Marital status 0.943
Married 84 (60.9) 167 (60.5)
Unmarried 54 (39.1) 109 (39.5)
Years of schooling, mean (±SD), yrs 10.7 (4.9) 10.8 (4.7) 0.882
Occupational status 0.459
Unemployed 96 (69.6) 182 (65.9)
Employed 42 (30.4) 94 (34.1)
Number of family member, mean (±SD) 5.0 (1.4) 4.3 (1.2) <0.001
Monthly household income, mean (±SD) in BDT 15275.3 (8382.0) 14420.2 (7066.7) 0.304
Tobacco use <0.001
Non users 65 (47.1) 236 (85.5)
Smoking only 34 (24.6) 20 (7.2)
Smokeless tobacco only 22 (15.9) 19 (6.9)
Both smoking and smokeless 17 (12.3) 1 (0.4)
Smoked tobacco users <0.001
Non user 87 (63.0) 255 (92.4)
Cigarette 32 (23.2) 17 (6.2)
Bidi 14 (10.1) 3 (1.1)
Hukka 5 (3.6) 1 (0.4)
Smokeless tobacco users* <0.001
Non users 99 (71.7) 256 (92.8)
Betel quid with tobacco leaf 37 (26.8) 20 (7.2)
Zarda 35 (25.4) 16 (5.8)
Gul 6 (4.3) 2 (0.7)
Number of cigarette/bidi/hukka per day <0.001
Non user 87 (63.0) 255 (92.4)
1-5 8 (5.8) 5 (1.8)
6-10 16 (11.6) 7 (2.5)
>10 27 (19.6) 9 (3.3)
Alcohol use 19 (13.8) 4 (1.4) <0.001
Insufficient sleep 75 (54.3) 95 (34.4) <0.001
Mental stress 93 (67.4) 89 (32.2) <0.001
Data are mean (SD, standard deviation) or n (%).
Abbreviations: BDT, Bangladeshi Taka; 1 USD = 84 Taka.
* Simultaneous consumption of >1 type of tobacco is common among smokeless tobacco users in Bangladesh.
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users, 24.6% were only smokers, 15.9% only smokeless
tobacco users, and 12.3% used both. The respective
figures among controls were 14.5%, 7.2%, 6.9%, and
0.4% (P <0.001 for all). Alcohol drinking, insufficientsleep and mental stress were more prevalent among
cases compared to controls.
The conditional logistic regression analysis found that
migraine had higher odds of exposure to smoked tobacco
use, smokeless tobacco use, and both compared to control
Table 2 Odds ratios for migraine by type of tobacco use
Tobacco use Crude OR (95% CI) P value Adjusted OR (95% CI) P value
Non users 1 Ref 1 Ref
Smoked tobacco 13.3 (5.5-32.4) <0.001 6.6 (2.2-19.6) 0.001
Smokeless tobacco 8.4 (3.3-21.3) <0.001 5.8 (1.9-17.4) 0.001
Both Smoked tobacco and Smokeless tobacco 133.9 (15.6-1146.0) <0.001 54.2 (4.3-684.4) 0.002
Abbreviations: OR, Odds ratio, adjusted for alcohol use, insufficient sleep, mental stress and number of family member; CI, Confidence interval.
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insufficient sleep, mental stress, and number of family
members); adjusted odds ratio (aOR) was 6.6 (95%
confidence interval [CI] = 2.2-19.6, P = 0.001), 5.8 (95%
CI = 1.9-17.4, P = 0.001), and 54.2 (95%CI = 4.3-684.4,
P = 0.002), respectively as shown in Table 2. The aOR
of cigarette/bidi/hukka smoking for different doses
was 5.5 (95%CI = 1.2-24.8, P = 0.027) for 1–5 times
per day, 6.3 (95%CI = 1.8-21.2, P = 0.003) for 6–10
times per day, and 6.7 (95%CI = 1.9-23.2, P = 0.003)
for >10 times per day relative to non users (Table 3).
Discussion
To our knowledge, this is the first study to examine the
association between smokeless tobacco use and migraine
headache. We observed that smokeless tobacco users
also had comparable odds of developing migraine like that
of smokers within the limits inherent in case–control
studies. Our findings that odds of smokers for migraine are
higher compared to controls have been already reported
[9,10,12-15]. Our study adds smokeless tobacco use to the
list of risk factors for migraine headaches. Together, these
studies provide evidence that both smokeless tobacco users
and smokers are more likely to develop migraine headache
compared to their counterparts.
Review of the literature showed that the associations
between smoking and migraine headaches are not consist-
ent [2,7-15]. Our finding of strong association between
migraine and smoking is in agreement with some studies
[2,9,10,12-15], although several studies did not find any
association between them [7,8,11]. One large descriptive
study also reported some sort of relationship between
smoking and migraine [20]. Chen et al. [20], based on 508
migraine cases and 3192 controls, observed that there
were more smokers in migraine group compared to
non-migraine group. This variation between the findingsTable 3 Odds ratios for migraine by frequency of smoked tob





Abbreviations: OR, Odds ratio, adjusted for alcohol use, insufficient sleep, mental stcould be due to the difference in study design, sample size
and study population. For example, Nazari et al. study [7]
conducted among women only where smoking is rarely
practiced in female gender. Fernandez-de-las-penas et al.’s
study [11] did not follow the IHS classification for
migraine diagnosis. Takeshima et al. study [8], on the other
hand, was based on secondary data which was not primarily
designed to examine the association between smoking and
migraine headache. Our findings showed that there were
some sort of dose–response relationship between frequency
of smoking and migraine. Odds ratio of migraine headache
increased among smokers with the increase in frequency of
smoking per day. This feature is consistent with the
findings reported by Lopez-Mesonero et al. [6] and
Tietjen et al. [14].
Smokeless tobacco use is widely prevalent in South
Asian countries [21]. In Bangladesh, among females,
94.7% of current tobacco users used only smokeless
tobacco [17]. Like other South Asian countries, the
traditional values do not widely permit women to smoke
cigarettes. However, there is no such taboo against using
smokeless tobacco [22]. Younger people hesitate to
smoke in front of their elders; they never smoke in the
presence of their parents and seniors. Smokeless tobacco
is an exception. Chewing betel quid (betel leaf ) with
sliced betel nut and dried tobacco leaf is considered as a
normal social behavior. Besides, these are considered as
a symbol of hospitality in the rural areas. Even the poor
would feel embarrassed if these were not offered to a
guest [23]. It is a social custom to serve guests by betel
quid and dried tobacco product after meal in a family or
social event. As smokeless tobacco contains several
hazardous compounds like that of smoked tobacco,
awareness against this harmful habit is must to prevent
tobacco-related health conditions [24]. Campaigns against
all kinds of tobacco use involving doctors, local healthacco use
P value Adjusted OR (95% CI) P value
Ref 1 Ref
0.013 5.5 (1.2-24.8) 0.027
<0.001 6.3 (1.8-21.2) 0.003
<0.001 6.7 (1.9-23.2) 0.003
ress and number of family member; CI, Confidence interval.
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and local community leaders could be more effective than
other strategies. Health hazards warnings, along with
nicotine and tar level, should be labeled on packets of
dried tobacco leaf. Anti-tobacco campaigns by public
agencies and mass media should also include smokeless
tobacco in their agenda. Any efforts to reduce the use of
smokeless tobacco will not only reduce migraine but also
other chronic conditions [20].
Our study has several strengths which include IHS
defined migraine (without aura) diagnosis, and selection
of cases and controls from the same population.
Although, we were aware about the issue of careful
selection of controls and we have chosen controls with no
past and present history of migraine attack, possibility of
significant effect measures could not be eliminated. This
was the major limitation of our study. Others limitations
include: 1) Since our study was a prevalent case–control
study, the ORs did not exactly demonstrate the relative
risk of migraine incidence, but the association with those
who visited the hospital a various length of period after
the first pain attack. The cases with repeated pain
and longer history were likely to be sampled. 2) Our
study is subject to recall bias due to its study design.
3) Our findings may have limited generalizability as
our study was based on a tertiary hospital. 4) Despite
multivariable adjustment technique, there could be
additional potential confounders which we could not
measure. 5) Unavailability of dose–response data regarding
smokeless tobacco was an important shortcoming in our
study. 6) We couldn’t measure mental stress by using any
standard scale. 7) Finally, this prevalent case–control study
prevents our ability to establish causal relationships or
pathways to migraine headache as we do not know whether
outcome was preceded by exposure or not. Further
larger scale cohort study is needed to establish the
association between tobacco consumption, specially
smokeless tobacco and migraine.Conclusions
This study indicated that both smoking and smokeless
tobaccos were associated with migraine headache,
although there were several limitations. As use of
smokeless tobacco is widely prevalent in Bangladesh
and has become a cultural norm especially in rural
area, a multi-pronged approach involving community
leaders, mass media, and anti-tobacco organizations is
needed to formulate tobacco use cessation program
along with smoked tobacco to reduce the burden of
migraine in Bangladesh.Competing interests
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